CKLF and stroke disorder: Despite low exposure in vivo, M1 had an IC50 value of 2.12 × 10−8 M as an antagonist of the potent stroke target chemokine-like factor 1 in previous research (Li et al., 2010; Kong et al., 2011; Sun et al., 2013; Kong et al., 2014).